Future Genomics 2023 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest in multiomics, next-generation sequencing, and diagnostics for the advancement of global healthcare.


Benefits of attending include:

  • Two days of in-depth presentations revealing the very latest market intelligence addressing the industry’s collective challenges by sharing results and experiences.
  • Exclusive networking opportunity, a chance to engage with other professionals with shared challenges and experiences in this fast-developing sector.
  • Updates on regional projects and research led by leading genomics experts detailing their experiences, findings, and new proposals.
  • Technical presentations from across the industry showcasing the latest results from recent tests and trials, technological developments, and new technical know-how.
  • New case studies on specific examples from leading industry experts in multiomics and next-generation sequencing initiatives.
  • Unique opportunity to integrate with a multitude of biotech, pharmaceutical, diagnostic companies, and to seek new opportunities in this evolving industry.


Attending this conference will enable you to:

  • Understand the current market dynamics of genomics and the healthcare industry
  • Learn how to develop strategies for the advancement of global healthcare using the latest technologies and techniques
  • Hear the latest trends with an overview of the year and projections for the biotech and pharmaceutical industries
  • Discuss new innovations and technological developments in multiomics and next-generation sequencing
  • Access different ideas and perspectives from a multitude of experts and allied industries combining regional experiences


Who should attend?

This event is aimed at leading biotech, pharmaceutical, and diagnostic companies, along with government and policy think tanks, seeking to learn more about the latest technologies and technical know-how in genomic sequencing for clinical diagnostics and to build alliances for developing a global genomic surveillance system. Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, Managers, and Stakeholders involved in:


Genomics Research

Next-Generation Sequencing

Business Development

Translational Research


Clinical Trials and Approvals

Multiomics Research

Biotechnology Research

Manufacturing Research & Innovation

Clinical Diagnostics


Research and Development

Companion Diagnostics


Strategy, Projects, & Public Affairs

Clinical Trials

Spatial Biology

Sales and Marketing Initiatives


System Biology and Research

Legal and Regulatory


Precision Medicine

Equipment Certification Services

Molecular Medicine

Laboratory Equipment

News Reporting and Journalism


From the following industries and companies:

Biotechnology Companies

Genomic and Pathology Laboratories

Associations and Alliances

Pharmaceutical Companies

Clinical Research Organizations

Universities and Academia

Biopharmaceutical Companies

Precision Medicine Researchers

Research and Development

Diagnostic Companies

NGS Equipment Manufacturers

Government Agencies

Global Healthcare Providers

Omics Research Companies

Consultants and Advisors

Next-Generation Sequencing Companies

Spatial Biology Companies

Public Consultation Groups

Cancer Research & Treatment

Molecular Medicine Companies

Legal and Compliance Services

Translational Research Companies

Non-Governmental Organisations

News Reporters and Journalists


Book now
To secure your place at Future Genomics 2023, or if you require more information, please contact delegates@iQ-Hub.com.

Get In Touch

Subscribe for updates:

Back to Top